ScholarIQanswers from OpenAlex & ORCID
Michael H. Weisman
ResearcherPublications, citations & collaboration network
Michael H. Weisman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael H. Weisman have?
ScholarIQindexed works
Michael H. Weisman has 537 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael H. Weisman have?
ScholarIQcitation count
Michael H. Weisman has 37,616 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael H. Weisman?
ScholarIQh-index
Michael H. Weisman has an h-index of 94 in OpenAlex.
What is the i10-index of Michael H. Weisman?
ScholarIQi10-index
Michael H. Weisman has an i10-index of 308 in OpenAlex.
What is the ORCID of Michael H. Weisman?
ScholarIQorcid
The ORCID for Michael H. Weisman is on the source record.
What is the OpenAlex record for Michael H. Weisman?
ScholarIQopenalex
The OpenAlex for Michael H. Weisman is on the source record.
What are the most-cited papers on Michael H. Weisman?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley Cohen, Karel Pavelká, Ronald van Vollenhoven, John T. Sharp, John L. Perez, G Spencer-Green
Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis
Daniel O. Clegg, Domenic J. Reda, Crystal L. Harris, Marguerite Klein, James R. O’Dell, Michele Hooper, John Bradley, Clifton O. Bingham, Michael H. Weisman, Christopher G. Jackson, Nancy E. Lane, John J. Cush, Larry W. Moreland, H. Ralph Schumacher, Chester V. Oddis, Frederick Wolfe, Jerry A. Molitor, David E. Yocum, Thomas J. Schnitzer, Daniel E. Furst, Allen D. Sawitzke, Helen Shi, Kenneth D. Brandt, Roland W. Moskowitz, H. James Williams
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ellen M. Ginzler, Mary Anne Dooley, Cynthia Aranow, Mimi Kim, Jill P. Buyon, Joan T. Merrill, Michelle Petri, Gary S. Gilkeson, Daniel J. Wallace, Michael H. Weisman, Gerald B. Appel